FilingFirehose · free AI preview
Jasper Therapeutics, Inc.
JSPR · AI-generated SEC analysis preview · refreshes when data changes
⚠️ Red flag 8-Ks: 2
Types: Delisting, Officer Departure
Jasper Therapeutics has filed two material 8-Ks in the past 90 days: a delisting notice (June 2026) and an officer departure (May 2026). These filings signal potential governance instability and trading risk that warrant deeper analysis. The full $49 Report adds dilution trajectory modeling, 12-month filing context, financing history, and AI-detected stress signals across SEC documents to quantify shareholder risk exposure.
Want the full 5-section $49 Report on JSPR?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.